151 related articles for article (PubMed ID: 35134656)
1. Apolipoproteins and lipoprotein(a) as factors modulating fibrin clot properties in patients with severe aortic stenosis.
Siudut J; Natorska J; Wypasek E; Wiewiórka Ł; Ostrowska-Kaim E; Wiśniowska-Śmiałek S; Plens K; Musialek P; Legutko J; Undas A
Atherosclerosis; 2022 Mar; 344():49-56. PubMed ID: 35134656
[TBL] [Abstract][Full Text] [Related]
2. Patients scheduled for TAVI tend to form abnormal fibrin clots more resistant to lysis: the impact of age.
Jaworska-Wilczyńska M; Natorska J; Siudut J; Marzec K; Kowalik I; Hryniewiecki T; Undas A
Kardiol Pol; 2021; 79(7-8):796-803. PubMed ID: 34002842
[TBL] [Abstract][Full Text] [Related]
3. Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndrome.
Asztabski M; Wypasek E; Ząbczyk M; Undas A
Thromb Res; 2014 Nov; 134(5):945-51. PubMed ID: 25194881
[TBL] [Abstract][Full Text] [Related]
4. Plasma fibrin clot properties affect blood loss after surgical aortic valve replacement for aortic stenosis.
Mazur P; Natorska J; Sobczyk D; Gaweda B; Bartus K; Filip G; Kapelak B; Undas A
Eur J Cardiothorac Surg; 2019 Feb; 55(2):224-231. PubMed ID: 30063794
[TBL] [Abstract][Full Text] [Related]
5. Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: Association with lipoproteins and C-reactive protein.
Siudut J; Ząbczyk M; Wołkow P; Polak M; Undas A; Jawień J
Vascul Pharmacol; 2022 Jun; 144():106977. PubMed ID: 35283275
[TBL] [Abstract][Full Text] [Related]
6. Determinants of plasma fibrin clot lysis measured using three different assays in healthy subjects.
Siudut J; Iwaniec T; Plens K; Pieters M; Undas A
Thromb Res; 2021 Jan; 197():1-7. PubMed ID: 33157491
[TBL] [Abstract][Full Text] [Related]
7. Plasma fibrin clot proteomics in patients with acute pulmonary embolism: Association with clot properties.
Bryk AH; Natorska J; Ząbczyk M; Zettl K; Wiśniewski JR; Undas A
J Proteomics; 2020 Oct; 229():103946. PubMed ID: 32810596
[TBL] [Abstract][Full Text] [Related]
8. Plasma fibrin clot proteomics in healthy subjects: Relation to clot permeability and lysis time.
Ząbczyk M; Stachowicz A; Natorska J; Olszanecki R; Wiśniewski JR; Undas A
J Proteomics; 2019 Sep; 208():103487. PubMed ID: 31425886
[TBL] [Abstract][Full Text] [Related]
9. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
[TBL] [Abstract][Full Text] [Related]
10. Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.
Goldman S; Frączek P; Szklanny K; Papuga-Szela E; Stanisz A; Undas A
Thromb Haemost; 2018 Apr; 118(4):654-663. PubMed ID: 29618152
[TBL] [Abstract][Full Text] [Related]
11. Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
Matusik PT; Matusik PS; Kornacewicz-Jach Z; Małecka B; Ząbek A; Undas A
Int J Cardiol; 2017 Sep; 243():244-250. PubMed ID: 28571619
[TBL] [Abstract][Full Text] [Related]
12. A prothrombotic state and denser clot formation in patients following acute limb ischemia of unknown cause.
Karpińska IA; Nowakowski T; Wypasek E; Plens K; Undas A
Thromb Res; 2020 Mar; 187():32-38. PubMed ID: 31951936
[TBL] [Abstract][Full Text] [Related]
13. Prothrombotic alterations in plasma fibrin clot properties in thyroid disorders and their post-treatment modifications.
Mazur P; Sokołowski G; Hubalewska-Dydejczyk A; Płaczkiewicz-Jankowska E; Undas A
Thromb Res; 2014 Aug; 134(2):510-7. PubMed ID: 24962680
[TBL] [Abstract][Full Text] [Related]
14. Impaired Fibrinolysis in Patients with Isolated Aortic Stenosis is Associated with Enhanced Oxidative Stress.
Siudut J; Natorska J; Wypasek E; Wiewiórka Ł; Ostrowska-Kaim E; Wiśniowska-Śmiałek S; Plens K; Legutko J; Undas A
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32630544
[TBL] [Abstract][Full Text] [Related]
15. Effect of high-dose statin therapy on coagulation factors: Lowering of factor XI as a modifier of fibrin clot properties in coronary artery disease.
Stępień K; Siudut J; Konieczyńska M; Nowak K; Zalewski J; Undas A
Vascul Pharmacol; 2023 Apr; 149():107153. PubMed ID: 36774992
[TBL] [Abstract][Full Text] [Related]
16. Therapy with high-dose statins reduces soluble P-selectin: The impact on plasma fibrin clot properties.
Siudut J; Pudło J; Konieczyńska M; Polak M; Jawień J; Undas A
Int J Cardiol; 2023 Feb; 373():110-117. PubMed ID: 36410546
[TBL] [Abstract][Full Text] [Related]
17. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
18. Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk.
Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
Sci Rep; 2020 Jul; 10(1):11433. PubMed ID: 32651425
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
Szczepaniak P; Zabczyk M; Undas A
PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype.
Natorska J; Corral J; de la Morena-Barrio ME; Bravo-Pérez C; Bagoly Z; Bereczky Z; Treliński J; Witkowski M; Klajmon A; Undas A; Ząbczyk M
Thromb Haemost; 2023 Sep; 123(9):880-891. PubMed ID: 37201530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
